New fda drug approval

NEW FDA DRUG APPROVAL

Medicine: Evkeeza

Active ingredient: evinacumab

Indication: homozygous familial hypercholesterolemia

Mechanism: evinacumab blocks angiopoietin-like protein 3 (ANGPTL3) – allowing faster breakdown of fats that lead to high cholesterol.